Come and join us on 6 July and hear 4 AIM CEO’s speak. Brad George, Orosur CEO updates us on Colombia’s Tier-1 gold mine potential, Cliff Gross, CEO at Tekcapital explains how investors benefit from a special dividend. Please register here.
The warrants are two years and I believe at 28.5p. The warrants have yet to be delivered as they generally take 2nd place to the new placing shares being issued. The booking of placing shares only took place Thursday with settlement 1st June so it may be difficult for new shares to be sold. I will be holding and very happy to get a decent allocation at 22p and it is the warrant's that will be extremely valuable to both the company and holders.
RE: Since deleted GlassDoor review29 May 2021 21:49
Glassdoor is known for good and bad posts and generally the bad can be quite damning to any company. At the end of December there were three very damning write ups by Bidstack staff/ex staff. Those three all disappeared also but I did take a screen shot at the time. I am aware that companies can involve their legal teams to have bad posts removed especially if they are clear in there mind as to who posted them. All non news quite frankly.
True finnovator, but given the year is now forecast at £4m it is difficult in my view for 1H 21 to be above 2H 20 by any meaningful number. I think we may see 1H 21 at around £1.25m (up an316%) and 2H 21 coming in at £2.75m (up 96%) Just my views and good for people to challenge and counter.
Hi Trueinvest, you are likely more up to speed. I only check in on Bids from time to time so your numbers may be closer to the reality. Bear in mind that R&D credits can take time. I have had many delays in HMRC processing so I would suggest that Macca the CFO will discount that number from his forecast monthly numbers until it arrives in the bank?
Holland & Barratt sales up 500% per week26 May 2021 20:38
So the Chairman talked hard numbers..... as follows:- - H&B revenue was at £11/12k per week. - Love Hemp spent £300k marketing campaign across a year and - H&B revenues have risen to £70k per week - Annualised come in at £3.64m a year from one outlet - Up to a 536% rise in sales
clark777, Year end was around £2.35m cash. R&D tax credit January guessing around £800k plus as end January 2021 cash was £2.76m (or thereabouts) Forecast loss of £7.9m (Stifel latest broker note) which equates to a loss of £658,333 per month So end Month cash should look like this:- - end Feb £2.1m - end Mar £1.44m - end Apr £785k - end May £126k
Clearly, the above using known released numbers so not fully accurate but likely close especially as revenues are 2nd half weighted so 1st 21 revenues are down on 2nd half 2020.
Also, a further R&D credit is due by end June for year end Dec 2020 but likely smaller than January's.
They seem to be on fumes so I gather they have been presenting through their brokers for last two weeks.
The issue I see is that trust in the management and the NAV are two things. The markets look at NAV and will mark the share price accordingly, and unfortunately we are likely to see sub 100p tomorrow. The trust in the management is why shareholders will likely hold and see this 'crash' through...
So the board of Novacyt need to do something to either support shareholder confidence or consider merger or sale to a larger group to deliver shareholder value --------------------------------------------------------------------------------------
My view is the company may be looking for a sale. We shall see in the coming year or so.